Interestingly, AEP is expressed at low levels in primary acute myeloid leukemia (AML), which hinders differential cleavage of polymorphic peptides and leads to strong T-cell recognition of both patient- and donor-type antigens when presented by HLA class II. This evidence concerns the gene LGMN and acute myeloid leukemia.